These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23642604)

  • 1. Cardiac myosin-binding protein C gene mutation expressed as hypertrophic cardiomyopathy and left ventricular noncompaction within two families: insights from cardiac magnetic resonance in clinical screening: Camuglia MYBPC3 gene mutation and MRI.
    Camuglia AC; Younger JF; McGaughran J; Lo A; Atherton JJ
    Int J Cardiol; 2013 Oct; 168(3):2950-2. PubMed ID: 23642604
    [No Abstract]   [Full Text] [Related]  

  • 2. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
    Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
    Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing (NGS) as a fast molecular diagnosis tool for left ventricular noncompaction in an infant with compound mutations in the MYBPC3 gene.
    Schaefer E; Helms P; Marcellin L; Desprez P; Billaud P; Chanavat V; Rousson R; Millat G
    Eur J Med Genet; 2014 Mar; 57(4):129-32. PubMed ID: 24602869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy with features of left ventricular non-compaction: how many diseases?
    Baker ML; W Fong M; Goldman B
    Int J Cardiol; 2011 May; 148(3):364-6. PubMed ID: 21420190
    [No Abstract]   [Full Text] [Related]  

  • 5. [One patient, one mutation and two cardiomyopathies - hypertrophic cardiomyopathy and left ventricular noncompaction].
    Faria R; Santos W; Camacho A; Marques N; Ferrinha R; Marques V; de Jesus I
    Rev Port Cardiol; 2012 Apr; 31(4):317-9. PubMed ID: 22386539
    [No Abstract]   [Full Text] [Related]  

  • 6. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy associated with left ventricular noncompaction cardiomyopathy and coronary fistulae: a case report. One genotype, three phenotypes?
    Delgado A; Moreira D; Rodrigues B; Correia E; Gama P; Cabral C; Marinho A; Santos O
    Rev Port Cardiol; 2013 Nov; 32(11):919-24. PubMed ID: 24268868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
    Page SP; Kounas S; Syrris P; Christiansen M; Frank-Hansen R; Andersen PS; Elliott PM; McKenna WJ
    Circ Cardiovasc Genet; 2012 Apr; 5(2):156-66. PubMed ID: 22267749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular noncompaction associated with a compound heterozygous MYBPC3 mutation.
    Finsterer J; Zarrouk-Mahjoub S
    Eur J Med Genet; 2014 Jul; 57(7):349. PubMed ID: 24769156
    [No Abstract]   [Full Text] [Related]  

  • 14. Left ventricular noncompaction associated with hypertrophic cardiomyopathy: echocardiographic diagnosis and genetic analysis of a new pedigree in China.
    Yuan L; Xie M; Cheng TO; Wang X; Zhu F; Kong X; Ghoorah D
    Int J Cardiol; 2014 Jun; 174(2):249-59. PubMed ID: 24698237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case images: Diagnosis of a rare combination of hypertrophic and left ventricular noncompaction cardiomyopathy using cardiac magnetic resonance imaging.
    Özyılmaz S; Akgül Ö; Kiriş A; Yıldırım A; Bakır İ
    Turk Kardiyol Dern Ars; 2016 Jul; 44(5):449. PubMed ID: 27439938
    [No Abstract]   [Full Text] [Related]  

  • 16. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
    Timmer SA; Germans T; Brouwer WP; Lubberink M; van der Velden J; Wilde AA; Christiaans I; Lammertsma AA; Knaapen P; van Rossum AC
    Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.
    Frustaci A; De Luca A; Guida V; Biagini T; Mazza T; Gaudio C; Letizia C; Russo MA; Galea N; Chimenti C
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Authors' response to the letter to the editor "Left ventricular noncompaction associated with a compound heterozygous MYBPC3 mutation".
    Schaefer E; Millat G
    Eur J Med Genet; 2014 Jul; 57(7):350-1. PubMed ID: 24830826
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.
    Hirota T; Kubo T; Kitaoka H; Hamada T; Baba Y; Hayato K; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Doi YL
    J Cardiol; 2010 Jul; 56(1):59-65. PubMed ID: 20350521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.